Breast Biophysical Examination (BBE): Potential Applications in Clinical Practice

  • Mirella Merson
  • Bruce A. Bach
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

The early detection of breast cancer and the prompt selection of appropriate therapy (generally involving a combination of modalities) have as their goal the reduction of the morbidity and mortality of this disease. Current opinion, based on large prospective studies, suggests that this aim can be achieved [1-6].

Keywords

Breast Cancer Breast Cancer Screening Conservative Surgery Extensive Intraductal Component Open Surgical Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brow ML and Fintor L: Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 1993 (25):113–118CrossRefGoogle Scholar
  2. 2.
    Van Ineveld BM, van Oortmarssen GJ, de Konig HJ, Boer R, van der Maas PJ: How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993 (29A):1663–1668PubMedCrossRefGoogle Scholar
  3. 3.
    Carter R, Glasziou P, van Oortmassen G, de Koning H, Stevenson C, Salked G, Boer R: Cost-effectiveness of mammographic screening in Australia. Aust J Public Health 1993 (17):42–50PubMedCrossRefGoogle Scholar
  4. 4.
    Miller AB: The cost and benefit of breast cancer screening. Am J Prev Med 1993 (9): 175–180PubMedGoogle Scholar
  5. 5.
    Harper GR and Englishbe BH: Prevention and screening for breast cancer. Cancer Detect Prev 1993 (17):551–555PubMedGoogle Scholar
  6. 6.
    Healey EA, Osteen RT, Schnitt SJ, Gelman R, Stomper PC, Connolly JL, Harris JR: Can the clinical and mammographic findings at presentation predict the presence of an extensive intraductal component in early stage breast cancer? Int J Radiat Oncol Biol Phys 1989 (17):1217–1221PubMedCrossRefGoogle Scholar
  7. 7.
    Randall T: Varied mammogram readings worry researchers. JAMA 1993 (269):2616PubMedCrossRefGoogle Scholar
  8. 8.
    Lannin DR, Harris RP, Swanson FH, Edwards MS, Swanson MS, Pories WJ: Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gyn Obstet 1993 (177):457–462Google Scholar
  9. 9.
    Lindfors KK and Rosenquist CJ: Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology 1994 (190):217–222PubMedGoogle Scholar
  10. 10.
    Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanotte G, Veronesi U: Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat 1990 (15):137–147PubMedCrossRefGoogle Scholar
  11. 11.
    Silvestrini R, Daidone MG, Valagussa P, Salvadori B, Rovini D, Bonadonna G: Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treat Rep 1987 (71):375–379PubMedGoogle Scholar
  12. 12.
    Silvestrini R, Daidone MG, Valagussa G, Di Fronzo G, Mezzamotte G, Mariani L, Bonadonna G: 3H Thymidine labeling index as a prognostic indicator in node positive breast cancer. J Clin Oncol 1990 (8): 1331–1326Google Scholar
  13. 13.
    Meyer JS and Province M: Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors. Br Cancer Res Treat 1988 (12): 191–204CrossRefGoogle Scholar
  14. 14.
    Tubiana M, Pojovie MH, Koscielny S, Chavaudra N, Malaise E: Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer 1989 (44): 17–22PubMedCrossRefGoogle Scholar
  15. 15.
    Fisher B, Redmond C, Poisson R et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989 (322):822–828CrossRefGoogle Scholar
  16. 16.
    Veronesi U, Banfi A, Salvadori B et al: Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990 (26):668–670PubMedCrossRefGoogle Scholar
  17. 17.
    Holland R, Connolly JL, Gelman R et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990 (8):113–118PubMedGoogle Scholar
  18. 18.
    Boyages J, Recht A, Connolly JL et al: Early breast cancer; predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990 (19):29–41PubMedCrossRefGoogle Scholar
  19. 19.
    Solin LL, Fowble BL, Schultz DJ, Goodman RL: The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 1991 (21):279–287PubMedCrossRefGoogle Scholar
  20. 20.
    Fowble B, Yeh IT, Schultz DJ et al: The role of mastectomy in patients with stage l-ll breast cancer presenting with gross multifocal or multicentric disease of diffuse microcalcifications. Int J Radiat Oncol Biol Phys 1993 (27):567–573PubMedCrossRefGoogle Scholar
  21. 21.
    Recht A and Harris JR: Selection of patients with early-stage breast cancer for conservative surgery and radiation. Oncology-Huntingt 1990 (4):23–30PubMedGoogle Scholar
  22. 22.
    Galinsky DL, Sharma M, Harsell WF, Griem KL, Murthy A: Primary radiation therapy to T1 and T2 breast cancer following conservative surgery. Which patients should be boosted? Am J Clin Oncol 1994 (17):60–63PubMedCrossRefGoogle Scholar
  23. 23.
    Recht A, Sadowsky NL, Cady B: Clinical problems in follow-up of patients after conservative surgery and radiotherapy. Surg Clin North Am 1990 (70):1179–1186PubMedGoogle Scholar
  24. 24.
    Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap IIY, Schell F: Multimodal treatment of locoregionally advanced breast cancer. Cancer 1983 (51):763–768PubMedCrossRefGoogle Scholar
  25. 25.
    Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986 (46): 2578–2581PubMedGoogle Scholar
  26. 26.
    Bonadonna G, Veronesi U, Brambilla C et al: Primary chemotherapy to avoid mastectomy in tumors with a diameter of three centimeters or more. JNCI 1990 (82): 1539–1545PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Mirella Merson
    • 1
  • Bruce A. Bach
    • 2
  1. 1.Department of Surgical OncologyIstituto Nazionale TumoriMilanoItaly
  2. 2.University of CaliforniaSan FranciscoUSA

Personalised recommendations